RVMD - Raymond James starts coverage of Revolution Medicines at outperform
2023-11-16 13:24:33 ET
More on Revolution Medicines
- Revolution Medicines: A March Halted By 'Lackluster' ESMO Readout
- Revolution Medicines, Inc. 2023 Q3 - Results - Earnings Call Presentation
- Revolution Medicines, Inc. (RVMD) Q3 2023 Earnings Conference Call Transcript
- SoftBank adds stakes in Neumora, Globalstar in Q3; stake in WeWork slashed
- Revolution Medicines and EQRx stockholders approve acquisition
For further details see:
Raymond James starts coverage of Revolution Medicines at outperform